Lexicon Pharmaceuticals, Inc. (LXRX) Revenue History
Lexicon Pharmaceuticals, Inc. (LXRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $83.34M |
| 2017-12-31 | $91.51M |
| 2018-12-31 | $62.85M |
| 2019-12-31 | $321.56M |
| 2020-12-31 | $23.44M |
| 2021-12-31 | $298.00K |
| 2022-12-31 | $139.00K |
| 2023-12-31 | $1.11M |
| 2024-12-31 | $6.00M |
| 2025-12-31 | $49.80M |
How LXRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NKTR | Nektar Therapeutics | $55.23M |
| AGIO | Agios Pharmaceuticals Inc. | $54.03M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
These are five companies in the same sector as LXRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lexicon Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("LXRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LXRX | $2.33 | +1.09% | 0.57M |
| 3 | ||||
| 4 | ||||
| 5 |